Anti-Semitism in American Universities & RSV Vaccines for 60+

Shortly after the news of what happened in Israel, on October 7th, reached the eyes of the world condemnation followed but at least two American academics couldn’t believe what they were hearing and not hearing from leading universities in the U.S. The two wrote an article titled "Why Was It So Hard for Elite Universities to Condemn Hamas Terrorism?" One of their opening lines pulls no punches, "What they said, and what they did not say, provides a window into the culture of intellectual and moral rot and cowardice that reigns at these once great institutions." Co-author Michael Poliakoff, adjunct professor of classical studies George Mason University in Virginia, joins Bob Komsic to discuss. AND Remember the "triple-demic" of last fall and winter? Seasonal flu, COVID-19, and Respiratory Syncytial Virus (RSV). With a new highly effective RSV vaccine recently approved for those 60 and older, the National Institute on Ageing feels a lot more needs to be done as vaccination rates in this age group are underwhelmingly low. Arushan Arulnamby co-authored the Institute’s report on this and joins Bob Komsic to explain.